首页 > 最新文献

Health Economics Review最新文献

英文 中文
Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand. 肾去神经治疗高血压:来自中国大陆、日本和泰国的成本-效果观察。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-13 DOI: 10.1186/s13561-025-00669-w
Dai Lian, Yue Suo, Ruoyan Gai, Ning Li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen

Background: Renal denervation (RDN) has been introduced as a novel non-pharmacological intervention for patients with hypertension that is poorly controlled by pharmacological means. Our study aims to evaluate the cost-effectiveness of the Netrod RDN treatment plus antihypertensives compared with antihypertensives alone for hypertension in Mainland China, Japan and Thailand.

Methods: A Markov decision-analytic model was developed to simulate the long-term clinical events, quality-adjusted life years (QALYs) and related costs among patients who underwent RDN regimen and antihypertensive regimen in line with Netrod-HTN trial, with yearly cycles over a 30-year horizon. This study adopted the perspectives of the healthcare systems. Cost and utility inputs were collected from published literature, price databases, expert consultations, and hospital information systems. Both costs and outcomes were discounted at a rate of 5%. Model validation, univariate and probabilistic sensitivity analyses, and scenario analyses were conducted to verify the robustness of the results.

Results: Compared with the antihypertensive regimen alone, the RDN regimen yielded a 30.61% reduction in cardiovascular, cerebral and renal events. Cost-effectiveness analysis showed the RDN regimen yielded the most favorable incremental cost-effectiveness ratio in Japan at $3,451 per QALY, followed by Thailand at $13,932 per QALY, and Mainland China at $19,049 per QALY. Sensitivity and scenario analyses confirmed the robustness of the findings.

Conclusions: Netrod RDN is a cost-effective intervention from the healthcare system perspective in Mainland China, Japan, and Thailand. However, its cost-effectiveness varies across countries, reflecting differences in socioeconomic contexts. In middle- and low-income countries, appropriate pricing strategies may play a key role in enhancing its affordability and cost-effectiveness.

背景:肾去神经支配(RDN)已被介绍为一种新的非药物干预高血压患者,药物手段控制不佳。本研究旨在评价Netrod RDN联合降压药治疗高血压与单独降压药治疗高血压在中国大陆、日本和泰国的成本-效果。方法:建立马尔可夫决策分析模型,模拟采用Netrod-HTN试验的RDN方案和降压方案患者的长期临床事件、质量调整生命年(QALYs)和相关费用,年周期超过30年。本研究采用医疗保健系统的观点。成本和效用输入收集自已发表的文献、价格数据库、专家咨询和医院信息系统。成本和结果均按5%折现。通过模型验证、单变量和概率敏感性分析以及情景分析来验证结果的稳健性。结果:与单独降压方案相比,RDN方案降低了30.61%的心血管、脑和肾事件。成本-效果分析显示,RDN方案在日本产生了最有利的增量成本-效果比,每个QALY为3,451美元,其次是泰国,每个QALY为13,932美元,中国大陆为每个QALY 19,049美元。敏感性和情景分析证实了研究结果的稳健性。结论:从中国大陆、日本和泰国的医疗系统角度来看,Netrod RDN是一种具有成本效益的干预措施。然而,其成本效益因国家而异,反映了社会经济背景的差异。在中低收入国家,适当的定价战略可在提高其可负担性和成本效益方面发挥关键作用。
{"title":"Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand.","authors":"Dai Lian, Yue Suo, Ruoyan Gai, Ning Li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen","doi":"10.1186/s13561-025-00669-w","DOIUrl":"10.1186/s13561-025-00669-w","url":null,"abstract":"<p><strong>Background: </strong>Renal denervation (RDN) has been introduced as a novel non-pharmacological intervention for patients with hypertension that is poorly controlled by pharmacological means. Our study aims to evaluate the cost-effectiveness of the Netrod RDN treatment plus antihypertensives compared with antihypertensives alone for hypertension in Mainland China, Japan and Thailand.</p><p><strong>Methods: </strong>A Markov decision-analytic model was developed to simulate the long-term clinical events, quality-adjusted life years (QALYs) and related costs among patients who underwent RDN regimen and antihypertensive regimen in line with Netrod-HTN trial, with yearly cycles over a 30-year horizon. This study adopted the perspectives of the healthcare systems. Cost and utility inputs were collected from published literature, price databases, expert consultations, and hospital information systems. Both costs and outcomes were discounted at a rate of 5%. Model validation, univariate and probabilistic sensitivity analyses, and scenario analyses were conducted to verify the robustness of the results.</p><p><strong>Results: </strong>Compared with the antihypertensive regimen alone, the RDN regimen yielded a 30.61% reduction in cardiovascular, cerebral and renal events. Cost-effectiveness analysis showed the RDN regimen yielded the most favorable incremental cost-effectiveness ratio in Japan at $3,451 per QALY, followed by Thailand at $13,932 per QALY, and Mainland China at $19,049 per QALY. Sensitivity and scenario analyses confirmed the robustness of the findings.</p><p><strong>Conclusions: </strong>Netrod RDN is a cost-effective intervention from the healthcare system perspective in Mainland China, Japan, and Thailand. However, its cost-effectiveness varies across countries, reflecting differences in socioeconomic contexts. In middle- and low-income countries, appropriate pricing strategies may play a key role in enhancing its affordability and cost-effectiveness.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"69"},"PeriodicalIF":3.3,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship. Côte科特迪瓦的治理和公共卫生支出:动态关系的审查。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-12 DOI: 10.1186/s13561-025-00627-6
Alliou Salihini Diarrassouba, Foungnigué Noé Coulibaly, Anzoumana Comoé

Background: The difficulties in mobilizing financial resources in developing countries combined with the low level of health of populations reveal the need to seek levers for optimal use of available resources. This paper aims at analyzing the dynamics of the relationship between governance and public health expenditure in Côte d'Ivoire as part of the "health for all" policy.

Methods: The estimates show, from a cointegration model based on the ARDL (self-regressive with staggered delays) approach and causality in the sense of that corruption influences and causes the increase in public health expenditure in the long term.

Results: The results includes poor health outcomes due to the diversion of resources on budgetary allocations. A 1% increase in the level of corruption generates 0.9% short-term and 0.5% long-term decrease in public health spending. Also, causality indicates a unidirectional link between the two variables ranging from corruption to the level of public health resources.

Conclusions: The authorities should therefore strengthen the institutional framework and the quality of central and internal governance of vertical health structures and programs in order to induce better use of resources likely to improve health outcomes.

背景:发展中国家在调动财政资源方面存在困难,加上人口的健康水平较低,这表明需要寻求最佳利用现有资源的手段。本文旨在分析Côte科特迪瓦作为“人人享有卫生保健”政策一部分的治理与公共卫生支出之间关系的动态。方法:通过基于ARDL(交错延迟自回归)方法的协整模型和因果关系的估计表明,腐败影响并导致了长期公共卫生支出的增加。结果:结果包括由于预算拨款的资源转移而导致的健康结果不佳。腐败程度每增加1%,公共卫生支出就会短期减少0.9%,长期减少0.5%。此外,因果关系表明,从腐败到公共卫生资源水平这两个变量之间存在单向联系。结论:因此,当局应加强机构框架和纵向卫生结构和方案的中央和内部治理的质量,以诱导更好地利用可能改善健康结果的资源。
{"title":"Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship.","authors":"Alliou Salihini Diarrassouba, Foungnigué Noé Coulibaly, Anzoumana Comoé","doi":"10.1186/s13561-025-00627-6","DOIUrl":"10.1186/s13561-025-00627-6","url":null,"abstract":"<p><strong>Background: </strong>The difficulties in mobilizing financial resources in developing countries combined with the low level of health of populations reveal the need to seek levers for optimal use of available resources. This paper aims at analyzing the dynamics of the relationship between governance and public health expenditure in Côte d'Ivoire as part of the \"health for all\" policy.</p><p><strong>Methods: </strong>The estimates show, from a cointegration model based on the ARDL (self-regressive with staggered delays) approach and causality in the sense of that corruption influences and causes the increase in public health expenditure in the long term.</p><p><strong>Results: </strong>The results includes poor health outcomes due to the diversion of resources on budgetary allocations. A 1% increase in the level of corruption generates 0.9% short-term and 0.5% long-term decrease in public health spending. Also, causality indicates a unidirectional link between the two variables ranging from corruption to the level of public health resources.</p><p><strong>Conclusions: </strong>The authorities should therefore strengthen the institutional framework and the quality of central and internal governance of vertical health structures and programs in order to induce better use of resources likely to improve health outcomes.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"68"},"PeriodicalIF":3.3,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran. 伊朗新冠肺炎疫情期间隔离政策的成本效益分析
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-04 DOI: 10.1186/s13561-025-00626-7
Morteza Tahamipour Zarandi, Kimia Haghbandeh

Background: The outbreak of COVID-19 posed significant health and economic challenges worldwide, prompting governments to implement various containment measures, including quarantine policies. This study examines the cost-benefit analysis of Iran's quarantine policy during the pandemic, evaluating its economic impact, public health outcomes, and overall effectiveness. The research explores the direct and indirect costs of quarantine, including reduced economic activity, government expenditures, and social consequences, while assessing the benefits in terms of lives saved, healthcare system relief, and long-term economic stability. Findings suggest that while quarantine measures imposed substantial financial burdens, they played a crucial role in controlling the virus's spread and preventing a greater economic and human toll. The study highlights the necessity of balancing public health interventions with economic sustainability, offering insights for future pandemic response strategies.

Methods: This study has used the cost-benefit analysis method. In the financial evaluation, benefits such as the reduction of fuel costs, gratuitous payments, and the benefit of credits paid to employees have been compared to expenses such as the average cost of corona treatment in the hospital and at home for the population of employees who have contracted the disease. Also, in the economic evaluation, the benefits of reducing electricity costs and food for employees, the willingness of people to pay the government for protective measures, and reducing overtime payments to employees compared to costs such as food for hospitalized employees, paying subsidies to employees and reducing GDP Has been studied.

Results: Application of quarantine is optimal from the view of government employees (financial point of view) with a benefit-cost ratio of 1.98, and the government's point of view (economic point of view) is cost-effective with a benefit-cost ratio of 2.68.

Conclusions: These results indicate that applying quarantine for employees benefits both the people and the government. Thus, the results of this study can be a guide for policymakers in managing similar disasters or the spread of other strains of the Coronavirus in the future.

背景:2019冠状病毒病的爆发给全球带来了重大的卫生和经济挑战,促使各国政府实施各种遏制措施,包括隔离政策。本研究考察了疫情期间伊朗隔离政策的成本效益分析,评估了其经济影响、公共卫生结果和总体有效性。该研究探讨了隔离的直接和间接成本,包括减少经济活动、政府支出和社会后果,同时评估了拯救生命、医疗系统救济和长期经济稳定方面的好处。调查结果表明,虽然隔离措施造成了巨大的财政负担,但它们在控制病毒传播和防止更大的经济和人员伤亡方面发挥了关键作用。该研究强调了平衡公共卫生干预与经济可持续性的必要性,为未来的大流行应对战略提供了见解。方法:本研究采用成本效益分析法。在财务评价中,将减少燃料费用、无偿付款和支付给雇员的抵免福利等福利与感染该疾病的雇员在医院和家中接受冠状病毒治疗的平均费用等费用进行了比较。此外,在经济评价中,研究了降低员工的电费和食品成本的效益,人们向政府支付保护措施的意愿,以及减少员工的加班费,而不是住院员工的食品,向员工支付补贴和减少GDP等成本。结果:从政府雇员的角度(财务角度)来看,实施隔离是最优的,其效益成本比为1.98;从政府的角度(经济角度)来看,其效益成本比为2.68。结论:本研究结果表明,对员工实行隔离对人民和政府都有利。因此,这项研究的结果可以为政策制定者在未来管理类似灾难或其他冠状病毒株的传播提供指导。
{"title":"Cost-benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran.","authors":"Morteza Tahamipour Zarandi, Kimia Haghbandeh","doi":"10.1186/s13561-025-00626-7","DOIUrl":"10.1186/s13561-025-00626-7","url":null,"abstract":"<p><strong>Background: </strong>The outbreak of COVID-19 posed significant health and economic challenges worldwide, prompting governments to implement various containment measures, including quarantine policies. This study examines the cost-benefit analysis of Iran's quarantine policy during the pandemic, evaluating its economic impact, public health outcomes, and overall effectiveness. The research explores the direct and indirect costs of quarantine, including reduced economic activity, government expenditures, and social consequences, while assessing the benefits in terms of lives saved, healthcare system relief, and long-term economic stability. Findings suggest that while quarantine measures imposed substantial financial burdens, they played a crucial role in controlling the virus's spread and preventing a greater economic and human toll. The study highlights the necessity of balancing public health interventions with economic sustainability, offering insights for future pandemic response strategies.</p><p><strong>Methods: </strong>This study has used the cost-benefit analysis method. In the financial evaluation, benefits such as the reduction of fuel costs, gratuitous payments, and the benefit of credits paid to employees have been compared to expenses such as the average cost of corona treatment in the hospital and at home for the population of employees who have contracted the disease. Also, in the economic evaluation, the benefits of reducing electricity costs and food for employees, the willingness of people to pay the government for protective measures, and reducing overtime payments to employees compared to costs such as food for hospitalized employees, paying subsidies to employees and reducing GDP Has been studied.</p><p><strong>Results: </strong>Application of quarantine is optimal from the view of government employees (financial point of view) with a benefit-cost ratio of 1.98, and the government's point of view (economic point of view) is cost-effective with a benefit-cost ratio of 2.68.</p><p><strong>Conclusions: </strong>These results indicate that applying quarantine for employees benefits both the people and the government. Thus, the results of this study can be a guide for policymakers in managing similar disasters or the spread of other strains of the Coronavirus in the future.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"67"},"PeriodicalIF":3.3,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144785620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the construction of high-speed rail crowding out the market for medical care services at county? Quasi-experimental evidence from China. 高铁建设是否挤占了县域医疗服务市场?来自中国的准实验证据。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-02 DOI: 10.1186/s13561-025-00661-4
Liu Yang, Zhongliang Zhou, Yawei Huang, Sha Lai, Chi Shen

Background: Public transportation, including high-speed rail (HSR), exerts a significant influence on people's health and health-related behaviors in various ways around the world. Several studies have investigated the impact of HSR on patients' health-seeking behavior, however, many issues regarding the impact of HSR remain to be investigated in depth. We aim to explore whether the effect of HSR on patients' health-seeking behavior crowds out the market for medical services in county regions based on China's practice.

Methods: The opening of two important HSR lines connecting two megacities in western China, Xi'an to Chengdu (opened on December 6, 2017) and Yinchuan to Xi'an (opened on December 26, 2020), were considered as quasi-experimental intervention, and Event Study and Synthetic Difference-in-Differences (DID) research design were applied in this study. A monthly report database about county-level hospitals of the health statistical data collection from 2017 to 2018 and 2020 to 2021 was used.

Results: There is no significant change in the total number of visits (TOV) and the number of bed days occupied by discharged persons (BDODP) in county-level hospitals before and after the opening of two major HSR lines being observed. The estimates of TOV from synthetic DID were 319.38 (95% CI, -761.01, 1399.77) and -915.69 (95% CI, -5079.07, 3247.68) for the two HSR lines, respectively. The estimates of BDODP from synthetic DID were -581.34 (95% CI, -1555.27, 392.59) and -960.62 (95% CI, -3932.40, 2011,17) for the two HSR lines, respectively. The results from the event study DID estimates are in line with the synthetic DID.

Conclusions: Our findings suggest that the construction of HSR does not substantially modify the utilization of medical services at the county level. Moreover the effect of the construction of HSR on the flow of patients to large hospitals may be an incremental effect. These findings hold important implications for infrastructure policy, suggesting that improvements in transportation can coexist with and perhaps even bolster local healthcare services without compromising their usage.

背景:包括高速铁路(HSR)在内的公共交通在世界范围内以各种方式对人们的健康和健康相关行为产生重大影响。一些研究已经探讨了高铁对患者就医行为的影响,但关于高铁影响的许多问题仍有待深入研究。我们的目的是根据中国的实践,探讨高铁对患者就医行为的影响是否挤占了县域医疗服务市场。​采用2017 - 2018年和2020 - 2021年县级医院卫生统计数据收集月报数据库。结果:两条主要高铁线路开通前后,县级医院总就诊人次(TOV)和出院病人病床天数(BDODP)无显著变化。合成DID对两条高铁线路的TOV估计分别为319.38 (95% CI, -761.01, 1399.77)和-915.69 (95% CI, -5079.07, 3247.68)。合成DID对两条高铁线路的BDODP估计分别为-581.34 (95% CI, -1555.27, 392.59)和-960.62 (95% CI, -3932.40, 2011,17)。事件研究DID估计的结果与合成DID一致。结论:高铁建设并未对县域医疗服务利用产生实质性影响。此外,高铁建设对大医院患者流量的影响可能是一种增量效应。这些发现对基础设施政策具有重要意义,表明交通的改善可以与当地医疗服务共存,甚至可能在不影响其使用的情况下加强当地医疗服务。
{"title":"Is the construction of high-speed rail crowding out the market for medical care services at county? Quasi-experimental evidence from China.","authors":"Liu Yang, Zhongliang Zhou, Yawei Huang, Sha Lai, Chi Shen","doi":"10.1186/s13561-025-00661-4","DOIUrl":"10.1186/s13561-025-00661-4","url":null,"abstract":"<p><strong>Background: </strong>Public transportation, including high-speed rail (HSR), exerts a significant influence on people's health and health-related behaviors in various ways around the world. Several studies have investigated the impact of HSR on patients' health-seeking behavior, however, many issues regarding the impact of HSR remain to be investigated in depth. We aim to explore whether the effect of HSR on patients' health-seeking behavior crowds out the market for medical services in county regions based on China's practice.</p><p><strong>Methods: </strong>The opening of two important HSR lines connecting two megacities in western China, Xi'an to Chengdu (opened on December 6, 2017) and Yinchuan to Xi'an (opened on December 26, 2020), were considered as quasi-experimental intervention, and Event Study and Synthetic Difference-in-Differences (DID) research design were applied in this study. A monthly report database about county-level hospitals of the health statistical data collection from 2017 to 2018 and 2020 to 2021 was used.</p><p><strong>Results: </strong>There is no significant change in the total number of visits (TOV) and the number of bed days occupied by discharged persons (BDODP) in county-level hospitals before and after the opening of two major HSR lines being observed. The estimates of TOV from synthetic DID were 319.38 (95% CI, -761.01, 1399.77) and -915.69 (95% CI, -5079.07, 3247.68) for the two HSR lines, respectively. The estimates of BDODP from synthetic DID were -581.34 (95% CI, -1555.27, 392.59) and -960.62 (95% CI, -3932.40, 2011,17) for the two HSR lines, respectively. The results from the event study DID estimates are in line with the synthetic DID.</p><p><strong>Conclusions: </strong>Our findings suggest that the construction of HSR does not substantially modify the utilization of medical services at the county level. Moreover the effect of the construction of HSR on the flow of patients to large hospitals may be an incremental effect. These findings hold important implications for infrastructure policy, suggesting that improvements in transportation can coexist with and perhaps even bolster local healthcare services without compromising their usage.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"66"},"PeriodicalIF":3.3,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health shocks and households' vulnerability to poverty in Nigeria: a quasi-experimental analysis. 尼日利亚健康冲击和家庭对贫困的脆弱性:一项准实验分析。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-21 DOI: 10.1186/s13561-025-00660-5
Paul Eze, Chimere O Iheonu

Health shocks are a critical driver of poverty in low- and middle-income countries (LMICs). This study investigates the impact of health shocks on household poverty risk in Nigeria and evaluates the protective capacity of existing health insurance mechanisms, using data from the 2023/2024 General Household Survey (n = 4,779 households). We first estimated household vulnerability using Chaudhuri's (2003) Vulnerability as Expected Poverty framework, addressing heteroskedasticity in consumption estimation via feasible generalized least squares. We then modeled the probability of household vulnerability following health shocks using probit regression. Finally, we implemented propensity score matching to isolate the effect of health shocks on households' vulnerability. Our results indicate that 56.1% and 59.2% of Nigerian households are vulnerable to poverty, using the international ($2.15/day) and national ($2.48/day) poverty lines, respectively. Vulnerable households are more prevalent in northern regions, rural areas, larger households, and poorer households. We found evidence that, based on the international poverty line, health shocks significantly increased the probability of household vulnerability (ATT = 0.053, SE = 0.023) compared to matched households without health shocks, with a slightly higher impact (ATT = 0.054, SE = 0.023) if using the national poverty line. Household size, dependency ratio, household head's education and employment status, and residence were significant predictors of vulnerability. Despite their potential, health insurance, covering only 2.2% of households, did not offer adequate protection against health shocks. This study provides robust evidence that health shocks increase households' vulnerability to poverty and perpetuate existing poverty. Financial protection measures need to be considered in broader poverty reduction policies.

健康冲击是低收入和中等收入国家贫困的一个关键驱动因素。本研究利用2023/2024年综合住户调查(n = 4,779户)的数据,调查了健康冲击对尼日利亚家庭贫困风险的影响,并评估了现有健康保险机制的保护能力。我们首先使用Chaudhuri(2003)的脆弱性作为预期贫困框架来估计家庭脆弱性,通过可行广义最小二乘法解决消费估计中的异方差问题。然后,我们使用概率回归对健康冲击后家庭脆弱性的概率进行建模。最后,我们实施倾向得分匹配来隔离健康冲击对家庭脆弱性的影响。我们的研究结果表明,按照国际贫困线(2.15美元/天)和国家贫困线(2.48美元/天)计算,分别有56.1%和59.2%的尼日利亚家庭容易陷入贫困。弱势家庭在北部地区、农村地区、大家庭和较贫困家庭更为普遍。我们发现证据表明,与没有健康冲击的匹配家庭相比,基于国际贫困线的健康冲击显著增加了家庭脆弱性的概率(ATT = 0.053, SE = 0.023),如果使用国家贫困线,影响略高(ATT = 0.054, SE = 0.023)。家庭规模、抚养比、户主教育和就业状况以及居住地是脆弱性的显著预测因子。尽管健康保险具有潜力,但仅覆盖2.2%的家庭的健康保险并没有为健康冲击提供足够的保护。这项研究提供了强有力的证据,表明健康冲击增加了家庭对贫困的脆弱性,并使现有贫困永久化。需要在更广泛的减贫政策中考虑财政保护措施。
{"title":"Health shocks and households' vulnerability to poverty in Nigeria: a quasi-experimental analysis.","authors":"Paul Eze, Chimere O Iheonu","doi":"10.1186/s13561-025-00660-5","DOIUrl":"10.1186/s13561-025-00660-5","url":null,"abstract":"<p><p>Health shocks are a critical driver of poverty in low- and middle-income countries (LMICs). This study investigates the impact of health shocks on household poverty risk in Nigeria and evaluates the protective capacity of existing health insurance mechanisms, using data from the 2023/2024 General Household Survey (n = 4,779 households). We first estimated household vulnerability using Chaudhuri's (2003) Vulnerability as Expected Poverty framework, addressing heteroskedasticity in consumption estimation via feasible generalized least squares. We then modeled the probability of household vulnerability following health shocks using probit regression. Finally, we implemented propensity score matching to isolate the effect of health shocks on households' vulnerability. Our results indicate that 56.1% and 59.2% of Nigerian households are vulnerable to poverty, using the international ($2.15/day) and national ($2.48/day) poverty lines, respectively. Vulnerable households are more prevalent in northern regions, rural areas, larger households, and poorer households. We found evidence that, based on the international poverty line, health shocks significantly increased the probability of household vulnerability (ATT = 0.053, SE = 0.023) compared to matched households without health shocks, with a slightly higher impact (ATT = 0.054, SE = 0.023) if using the national poverty line. Household size, dependency ratio, household head's education and employment status, and residence were significant predictors of vulnerability. Despite their potential, health insurance, covering only 2.2% of households, did not offer adequate protection against health shocks. This study provides robust evidence that health shocks increase households' vulnerability to poverty and perpetuate existing poverty. Financial protection measures need to be considered in broader poverty reduction policies.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"65"},"PeriodicalIF":3.3,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144691921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustainability of national health insurance scheme in Ghana: what is the effect of enrolment on retention and what are the constraints? 加纳国家医疗保险计划的可持续性:加入对保留的影响是什么?有什么限制?
IF 2.7 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-19 DOI: 10.1186/s13561-025-00619-6
Nicholas Kwame Essah

Background: Globally, health remains an important issue on governments agenda. Subsequently, the health insurance scheme was introduced in Ghana to reduce out-of-pocket payments for healthcare delivery. However, there are several challenges facing the scheme including continuous membership (retention) and financial constraints. These issues pose threat to the sustainability of the scheme. This study examined the effect of NHIS enrolment status on NHIS retention status in Ghana. The study further assesses the socio-demographic determinants of the NHIS retention and the major constraints in Ghana.

Methods: The expected utility theory of decision-making on health insurance underpins the study. The study's sample is drawn from the Ghana Living Standards Survey Round 7 (2016/2017) and the Heckman probit estimation technique is used to address the potential endogeneity in the sample selection process.

Results: There is positive effect of NHIS enrolment on the NHIS retention decision. Again, the study shows that the NHIS retention is driven by factors such as being female, being married, higher education, urban locality and household expenditure affect NHIS retention status positively. However, younger age and household size were found to deter NHIS retention status. The study further identified finance as the main constraint for the NHIS non- retention in Ghana (66.6%) followed by poor service delivery (12.5%). The financial constraint was higher for females (69.1%) than males (64.0%). It is also higher for rural areas (75.4%) than urban areas (48.8%).

Conclusions: Government should continue to strengthen efforts towards improving the quality of NHIS service delivery and monitor the implementation particularly in the rural areas. Again, government should continue to subsidize the health insurance premium particularly for the poor and the youth in Ghana. Also, public education should continue to be strengthened on the NHIS renewal process in Ghana.

背景:在全球范围内,卫生仍然是各国政府议程上的一个重要问题。随后,加纳推出了健康保险计划,以减少医疗保健服务的自付费用。然而,该计划面临一些挑战,包括持续的成员资格(保留)和财政限制。这些问题对该计划的可持续性构成威胁。本研究考察了加纳国家医疗卫生系统注册状况对国家医疗卫生系统保留状况的影响。该研究进一步评估了加纳保留国家卫生保健系统的社会人口决定因素和主要制约因素。方法:以健康保险决策的期望效用理论为基础进行研究。该研究的样本取自加纳生活水平调查第7轮(2016/2017),并使用Heckman概率估计技术来解决样本选择过程中的潜在内生性问题。结果:健保计划入组对健保计划保留决策有正向影响。研究再次表明,女性、已婚、高等教育程度、城市所在地和家庭支出等因素对高保保留状况有正向影响。然而,年轻的年龄和家庭规模阻碍了NHIS的保留状态。该研究进一步确定,在加纳,资金是NHIS不保留的主要制约因素(66.6%),其次是服务提供不良(12.5%)。女性(69.1%)比男性(64.0%)更感到经济拮据。农村地区(75.4%)也高于城市地区(48.8%)。结论:政府应继续加强努力,提高国家卫生健康系统的服务质量,并监测其实施情况,特别是在农村地区。此外,政府应继续补贴医疗保险费,特别是对加纳的穷人和青年。此外,应继续加强加纳国家卫生保健系统更新进程的公共教育。
{"title":"Sustainability of national health insurance scheme in Ghana: what is the effect of enrolment on retention and what are the constraints?","authors":"Nicholas Kwame Essah","doi":"10.1186/s13561-025-00619-6","DOIUrl":"10.1186/s13561-025-00619-6","url":null,"abstract":"<p><strong>Background: </strong>Globally, health remains an important issue on governments agenda. Subsequently, the health insurance scheme was introduced in Ghana to reduce out-of-pocket payments for healthcare delivery. However, there are several challenges facing the scheme including continuous membership (retention) and financial constraints. These issues pose threat to the sustainability of the scheme. This study examined the effect of NHIS enrolment status on NHIS retention status in Ghana. The study further assesses the socio-demographic determinants of the NHIS retention and the major constraints in Ghana.</p><p><strong>Methods: </strong>The expected utility theory of decision-making on health insurance underpins the study. The study's sample is drawn from the Ghana Living Standards Survey Round 7 (2016/2017) and the Heckman probit estimation technique is used to address the potential endogeneity in the sample selection process.</p><p><strong>Results: </strong>There is positive effect of NHIS enrolment on the NHIS retention decision. Again, the study shows that the NHIS retention is driven by factors such as being female, being married, higher education, urban locality and household expenditure affect NHIS retention status positively. However, younger age and household size were found to deter NHIS retention status. The study further identified finance as the main constraint for the NHIS non- retention in Ghana (66.6%) followed by poor service delivery (12.5%). The financial constraint was higher for females (69.1%) than males (64.0%). It is also higher for rural areas (75.4%) than urban areas (48.8%).</p><p><strong>Conclusions: </strong>Government should continue to strengthen efforts towards improving the quality of NHIS service delivery and monitor the implementation particularly in the rural areas. Again, government should continue to subsidize the health insurance premium particularly for the poor and the youth in Ghana. Also, public education should continue to be strengthened on the NHIS renewal process in Ghana.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"64"},"PeriodicalIF":2.7,"publicationDate":"2025-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12275349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144668667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calculating willingness-to-pay with discrete cost and random coefficients in discrete choice experiments. 离散选择实验中使用离散成本和随机系数计算支付意愿。
IF 2.7 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-18 DOI: 10.1186/s13561-025-00658-z
Clarence Ong, Alex R Cook, Ker-Kan Tan, Yi Wang

Objectives: This study provides step-by-step guidance to calculate willingness-to-pay (WTP) in discrete choice experiments that involve discrete cost. It highlights the limitations of assuming a linear disutility for cost in WTP calculation.

Methods: Five mixed-logit models were considered. Log-normal distributions were applied to cost parameters for four models under the assumption that utility (disutility) for cost should be negative (positive) or at least non-positive (non-negative) for all individuals. Piecewise linear utility in cost, using an iterative process, was proposed to calculate the WTP for the discrete cost models. Individual level simulations - considering individual random preference - were conducted to obtain the median WTP across all individuals and compared with the population mean WTP. A case study exploring preferences for colorectal cancer screening was used to demonstrate these models and methods.

Results: Models utilising discrete cost exhibited higher disutilities in cost at lower costs relative to models using continuous cost, but lower disutilities in cost at higher costs. Modelling using continuous cost tended to overestimate the WTP at low costs and underestimate the WTP at high costs. Adding a quadratic cost term only partially solved the problem, as the quadratic functional form may not capture the sharp change in preference for cost at low-cost levels. Divergent policy recommendations emerged when comparing results from continuous and discrete cost models. Although WTP was calculated using the population mean and the median across individuals, no systematic pattern was identified.

Conclusion: This study highlights the importance of incorporating discrete cost and selecting appropriate distribution assumptions for cost parameters to accurately derive the WTP.

目的:本研究为离散选择实验中涉及离散成本的支付意愿(WTP)的计算提供了一步一步的指导。它突出了在WTP计算中假设成本为线性负效用的局限性。方法:考虑5种混合logit模型。对数正态分布应用于四个模型的成本参数,假设成本的效用(负效用)应该是负的(正)或至少是非正的(非负)。针对离散成本模型,提出了分段线性成本效用的迭代方法来计算WTP。个体水平模拟-考虑个体随机偏好-进行,以获得所有个体的中位数WTP,并与总体平均WTP进行比较。一个探讨结肠直肠癌筛查偏好的案例研究被用来证明这些模型和方法。结果:与使用连续成本的模型相比,使用离散成本的模型在较低成本下的成本负效用更高,但在较高成本下的成本负效用更低。使用连续成本建模倾向于高估低成本时的WTP,而低估高成本时的WTP。添加二次成本项只能部分解决问题,因为二次函数形式可能无法捕捉低成本水平下对成本偏好的急剧变化。在比较连续和离散成本模型的结果时,出现了不同的政策建议。虽然WTP是使用个体的总体平均值和中位数计算的,但没有确定系统的模式。结论:本研究强调了纳入离散成本和选择合适的成本参数分布假设对于准确推导WTP的重要性。
{"title":"Calculating willingness-to-pay with discrete cost and random coefficients in discrete choice experiments.","authors":"Clarence Ong, Alex R Cook, Ker-Kan Tan, Yi Wang","doi":"10.1186/s13561-025-00658-z","DOIUrl":"10.1186/s13561-025-00658-z","url":null,"abstract":"<p><strong>Objectives: </strong>This study provides step-by-step guidance to calculate willingness-to-pay (WTP) in discrete choice experiments that involve discrete cost. It highlights the limitations of assuming a linear disutility for cost in WTP calculation.</p><p><strong>Methods: </strong>Five mixed-logit models were considered. Log-normal distributions were applied to cost parameters for four models under the assumption that utility (disutility) for cost should be negative (positive) or at least non-positive (non-negative) for all individuals. Piecewise linear utility in cost, using an iterative process, was proposed to calculate the WTP for the discrete cost models. Individual level simulations - considering individual random preference - were conducted to obtain the median WTP across all individuals and compared with the population mean WTP. A case study exploring preferences for colorectal cancer screening was used to demonstrate these models and methods.</p><p><strong>Results: </strong>Models utilising discrete cost exhibited higher disutilities in cost at lower costs relative to models using continuous cost, but lower disutilities in cost at higher costs. Modelling using continuous cost tended to overestimate the WTP at low costs and underestimate the WTP at high costs. Adding a quadratic cost term only partially solved the problem, as the quadratic functional form may not capture the sharp change in preference for cost at low-cost levels. Divergent policy recommendations emerged when comparing results from continuous and discrete cost models. Although WTP was calculated using the population mean and the median across individuals, no systematic pattern was identified.</p><p><strong>Conclusion: </strong>This study highlights the importance of incorporating discrete cost and selecting appropriate distribution assumptions for cost parameters to accurately derive the WTP.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"63"},"PeriodicalIF":2.7,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Behavioural insights in the underuse of cardiac resynchronisation therapy in heart failure: a pilot survey on incentive perceptions among referring cardiologists. 心脏再同步治疗在心力衰竭中使用不足的行为洞察:对转诊心脏病专家的激励观念的试点调查。
IF 2.7 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-18 DOI: 10.1186/s13561-025-00657-0
Joan Costa-I-Font, Georgiana Miler-Raicu, Elena Arbelo, Ruben Casado-Arroyo, Aya Sami, Eric Wei Seong Tee, Joseph Hazel, Laurent Roten, Tobias Reichlin, Haran Burri, Khaled Albouaini, Nikola Kozhuharov

Aims: Heart failure is a leading cause of hospitalisation in patients over 50, significantly impacting both quality of life and survival. Despite the well-established benefits of Cardiac Resynchronisation Therapy (CRT), its utilisation in clinical practice remains suboptimal. Traditional incentives, have shown limited effectiveness in increasing CRT referrals. This manuscript explores how behavioural economics can offer a novel framework for improving CRT uptake by leveraging behavioural incentives, particularly choice architecture and social incentives, to influence physician referral patterns.

Methods and results: We underscore key concepts of behavioural economics, including choice architecture (nudges, reference points, sludges), cognitive biases (status quo bias, overconfidence bias, availability bias), and social incentives, which are applied in designing incentives to promote CRT referrals. A survey was conducted with 51 physicians from six European countries, including electrophysiologists, heart failure specialists, and general cardiologists, recruited through cardiology networks and personal contacts. Participants rated their perceptions of five incentive strategies using a Likert scale (1-5). Behavioural incentives, such as peer comparison through league tables (social incentive) and decision prompts in electronic health records (choice architecture nudge), were perceived as more effective than traditional financial incentives, with a median Likert score of 4.0 [IQR 3.0-5.0] versus 2.5 [IQR 1.5-3.0] for traditional incentives (p < 0.001).

Conclusions: These findings suggest that interventions drawing on behavioural economics, particularly those utilising social incentives and choice architecture redesign, may offer more effective to increasing CRT referrals than traditional incentives. Such interventions could enhance CRT uptake and outcomes for heart failure patients.

目的:心力衰竭是50岁以上患者住院的主要原因,严重影响生活质量和生存率。尽管心脏再同步治疗(CRT)的益处已得到公认,但其在临床实践中的应用仍不理想。传统的激励措施在增加CRT转诊方面效果有限。本文探讨了行为经济学如何通过利用行为激励,特别是选择架构和社会激励,来影响医生转诊模式,从而为提高CRT的吸收提供一个新的框架。方法和结果:我们强调了行为经济学的关键概念,包括选择架构(轻推、参考点、污泥)、认知偏差(现状偏差、过度自信偏差、可得性偏差)和社会激励,这些概念应用于设计促进CRT转诊的激励措施。研究人员对来自6个欧洲国家的51名医生进行了调查,包括电生理学家、心力衰竭专家和普通心脏病专家,他们是通过心脏病学网络和个人联系招募的。参与者用李克特量表(1-5)评价他们对五种激励策略的看法。行为激励,如通过排名表进行同伴比较(社会激励)和电子健康记录中的决策提示(选择架构推动),被认为比传统的财务激励更有效,传统激励的中位数李克特得分为4.0 [IQR 3.0-5.0],而传统激励的中位数李克特得分为2.5 [IQR 1.5-3.0] (p结论:这些发现表明,利用行为经济学的干预措施,特别是那些利用社会激励和重新设计选择架构的干预措施,可能比传统的激励措施更有效地增加CRT转诊。这些干预措施可以提高心力衰竭患者CRT的吸收和预后。
{"title":"Behavioural insights in the underuse of cardiac resynchronisation therapy in heart failure: a pilot survey on incentive perceptions among referring cardiologists.","authors":"Joan Costa-I-Font, Georgiana Miler-Raicu, Elena Arbelo, Ruben Casado-Arroyo, Aya Sami, Eric Wei Seong Tee, Joseph Hazel, Laurent Roten, Tobias Reichlin, Haran Burri, Khaled Albouaini, Nikola Kozhuharov","doi":"10.1186/s13561-025-00657-0","DOIUrl":"10.1186/s13561-025-00657-0","url":null,"abstract":"<p><strong>Aims: </strong>Heart failure is a leading cause of hospitalisation in patients over 50, significantly impacting both quality of life and survival. Despite the well-established benefits of Cardiac Resynchronisation Therapy (CRT), its utilisation in clinical practice remains suboptimal. Traditional incentives, have shown limited effectiveness in increasing CRT referrals. This manuscript explores how behavioural economics can offer a novel framework for improving CRT uptake by leveraging behavioural incentives, particularly choice architecture and social incentives, to influence physician referral patterns.</p><p><strong>Methods and results: </strong>We underscore key concepts of behavioural economics, including choice architecture (nudges, reference points, sludges), cognitive biases (status quo bias, overconfidence bias, availability bias), and social incentives, which are applied in designing incentives to promote CRT referrals. A survey was conducted with 51 physicians from six European countries, including electrophysiologists, heart failure specialists, and general cardiologists, recruited through cardiology networks and personal contacts. Participants rated their perceptions of five incentive strategies using a Likert scale (1-5). Behavioural incentives, such as peer comparison through league tables (social incentive) and decision prompts in electronic health records (choice architecture nudge), were perceived as more effective than traditional financial incentives, with a median Likert score of 4.0 [IQR 3.0-5.0] versus 2.5 [IQR 1.5-3.0] for traditional incentives (p < 0.001).</p><p><strong>Conclusions: </strong>These findings suggest that interventions drawing on behavioural economics, particularly those utilising social incentives and choice architecture redesign, may offer more effective to increasing CRT referrals than traditional incentives. Such interventions could enhance CRT uptake and outcomes for heart failure patients.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"62"},"PeriodicalIF":2.7,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12273364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China. 彭普利单抗联合卡铂-紫杉醇作为中国转移性鳞状非小细胞肺癌一线治疗的成本-效果分析
IF 2.7 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-12 DOI: 10.1186/s13561-025-00656-1
Luwei Wang, Jiasheng Chen, Lihui Lin, Xiaowei Huang

Purpose: Squamous NSCLC (sqNSCLC), a subtype with few targetable mutations, is often diagnosed at advanced stages. Platinum-based chemo-therapy, the first-line treatment, yields median overall survival (OS) of less than or equal to one year, underscoring the need for better therapies. Penpulimab, a novel PD-1 inhibitor developed in China, is a humanized IgG1 antibody with a modified Fc region. Phase III trial data (AK105-302) showed penpulimab + carboplatin-paclitaxel (PEN-CP) significantly improved progression-free survival (PFS) and OS in metastatic sqNSCLC vs. placebo (CP), with a favorable safety profile. However, its high cost and lack of cost-effectiveness analyses warrant further study. This research evaluates PEN-CP's cost-effectiveness vs. CP from the Chinese healthcare perspective.

Methods: A three-state Markov model was developed to evaluate the cost-effectiveness of PEN-CP as a first-line treatment for metastatic sqNSCLC. Clinical efficacy data were sourced from the AK105-302 trial, while drug costs were derived from national tender prices. Additional costs and health utilities were obtained from published literature. The primary outcomes included total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs). To assess the robustness of the findings, both one-way and probabilistic sensitivity analyses were conducted.

Results: Compared to CP, the ICER for PEN-CP was $14,918.81 per QALY. The ICER values were below the willingness-to-pay (WTP) threshold of $38,060.00 per QALY. The key drivers of the model outcomes were the price of penpulimab, the PFS stage utility value, and the cost of optimal supportive care.

Conclusions: From the perspective of the Chinese healthcare system, penpulimab combined with first-line chemotherapy demonstrates is cost-effective at a willingness-to-pay threshold of $38,060.00 per QALY for patients with metastatic sqNSCLC and represents a promising first-line treatment option.

目的:鳞状非小细胞肺癌(sqNSCLC)是一种很少有靶向突变的亚型,通常在晚期被诊断出来。以铂为基础的化疗,一线治疗,产生的中位总生存期(OS)小于或等于1年,强调需要更好的治疗方法。Penpulimab是中国开发的一种新型PD-1抑制剂,是一种带有Fc区修饰的人源化IgG1抗体。III期试验数据(AK105-302)显示,与安慰剂(CP)相比,彭普利单抗+卡铂-紫杉醇(PEN-CP)可显著改善转移性sqNSCLC的无进展生存期(PFS)和OS,并具有良好的安全性。然而,其成本高,缺乏成本效益分析值得进一步研究。本研究从中国医疗保健的角度评估了PEN-CP与CP的成本效益。方法:建立一个三状态马尔可夫模型来评估PEN-CP作为转移性sqNSCLC一线治疗的成本-效果。临床疗效数据来源于AK105-302试验,药物成本来源于国家招标价格。从已发表的文献中获得了额外费用和保健费用。主要结局包括总成本、质量调整生命年(QALYs)和增量成本-效果比(ICERs)。为了评估研究结果的稳健性,我们进行了单向和概率敏感性分析。结果:与CP相比,PEN-CP的ICER为14918.81美元/ QALY。ICER值低于每个QALY $38,060.00的支付意愿阈值。模型结果的关键驱动因素是彭普利单抗的价格、PFS阶段效用值和最佳支持治疗的成本。结论:从中国医疗体系的角度来看,对于转移性sqNSCLC患者,penpulimumab联合一线化疗具有成本效益,其支付意愿阈值为38,060.00美元/ QALY,是一种有前景的一线治疗选择。
{"title":"Cost-effectiveness analysis of penpulimab plus carboplatin-paclitaxel as first-line treatment for metastatic squamous non-small-cell lung cancer in China.","authors":"Luwei Wang, Jiasheng Chen, Lihui Lin, Xiaowei Huang","doi":"10.1186/s13561-025-00656-1","DOIUrl":"10.1186/s13561-025-00656-1","url":null,"abstract":"<p><strong>Purpose: </strong>Squamous NSCLC (sqNSCLC), a subtype with few targetable mutations, is often diagnosed at advanced stages. Platinum-based chemo-therapy, the first-line treatment, yields median overall survival (OS) of less than or equal to one year, underscoring the need for better therapies. Penpulimab, a novel PD-1 inhibitor developed in China, is a humanized IgG1 antibody with a modified Fc region. Phase III trial data (AK105-302) showed penpulimab + carboplatin-paclitaxel (PEN-CP) significantly improved progression-free survival (PFS) and OS in metastatic sqNSCLC vs. placebo (CP), with a favorable safety profile. However, its high cost and lack of cost-effectiveness analyses warrant further study. This research evaluates PEN-CP's cost-effectiveness vs. CP from the Chinese healthcare perspective.</p><p><strong>Methods: </strong>A three-state Markov model was developed to evaluate the cost-effectiveness of PEN-CP as a first-line treatment for metastatic sqNSCLC. Clinical efficacy data were sourced from the AK105-302 trial, while drug costs were derived from national tender prices. Additional costs and health utilities were obtained from published literature. The primary outcomes included total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICERs). To assess the robustness of the findings, both one-way and probabilistic sensitivity analyses were conducted.</p><p><strong>Results: </strong>Compared to CP, the ICER for PEN-CP was $14,918.81 per QALY. The ICER values were below the willingness-to-pay (WTP) threshold of $38,060.00 per QALY. The key drivers of the model outcomes were the price of penpulimab, the PFS stage utility value, and the cost of optimal supportive care.</p><p><strong>Conclusions: </strong>From the perspective of the Chinese healthcare system, penpulimab combined with first-line chemotherapy demonstrates is cost-effective at a willingness-to-pay threshold of $38,060.00 per QALY for patients with metastatic sqNSCLC and represents a promising first-line treatment option.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"60"},"PeriodicalIF":2.7,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12255038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144620799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring patient and provider perspectives on health insurance effectiveness in cameroon: a qualitative study. 探索喀麦隆患者和提供者对健康保险有效性的看法:一项定性研究。
IF 2.7 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-12 DOI: 10.1186/s13561-025-00655-2
Adanze Nge Cynthia, Bülent Kılıç

Background: The global push to achieve universal health coverage (UHC) by 2030 has gained widespread attention, with many countries, including low- and middle-income nations like Cameroon, striving to implement reforms. However, financial, infrastructural, and systemic barriers make achieving UHC in Cameroon challenging. In pursuit of this goal, health insurance systems, particularly private health insurance, have been increasingly promoted to reduce out-of-pocket health expenses. However, the key question remains whether patients receive value for their money. This study aimed to examine the perspectives of patients and healthcare providers on the effectiveness of health insurance in Cameroon, with a focus on awareness, satisfaction, and the challenges influencing its accessibility and functionality.

Method: Following ethical approvals, this study employed a qualitative exploratory design, using key informant interviews (KII) to examine the perspectives of patients and healthcare providers on the effectiveness of health insurance in Cameroon. The study focused on awareness, satisfaction, and challenges influencing accessibility and functionality. Reflective thematic analysis was used to identify important aspects of our study.

Result: To ensure that the identified themes accurately represented the data and remained distinct, they were systematically reviewed and refined. This process resulted in five main themes: (1) Accessibility and Quality of Healthcare Services, (2) The Financial Paradox of Health Insurance, (3) Structural and Operational Challenges in the Health Insurance Framework, (4) Information Gaps and Awareness about Health Insurance, and (5) Divergent Experiences and Perspectives on Health Insurance Effectiveness. All participants agreed that health insurance reduces out-of-pocket health costs. Uninsured patients cited high premiums, distrust in the healthcare system, and insufficient knowledge about insurance options as reasons for not enrolling. Insured patients expressed significant dissatisfaction with their insurance packages, particularly with lengthy reimbursement processes and inadequate medical coverage.

Conclusion: The findings indicate a general agreement on the benefits of health insurance in Cameroon. To improve enrolment and satisfaction, premiums need to be made affordable across all socioeconomic levels, and consider increasing information dissemination and publicity about insurance options. Streamlining reimbursement processes is also crucial.

背景:到2030年实现全民健康覆盖的全球努力得到了广泛关注,包括喀麦隆等低收入和中等收入国家在内的许多国家都在努力实施改革。然而,财政、基础设施和体制障碍使得在喀麦隆实现全民健康覆盖具有挑战性。为了实现这一目标,医疗保险制度,特别是私人医疗保险,已越来越多地得到推广,以减少自付医疗费用。然而,关键问题仍然是病人是否物有所值。本研究旨在研究喀麦隆患者和医疗保健提供者对医疗保险有效性的看法,重点关注意识、满意度以及影响其可及性和功能的挑战。方法:在伦理批准后,本研究采用定性探索性设计,使用关键线人访谈(KII)来检查喀麦隆患者和医疗保健提供者对医疗保险有效性的看法。该研究关注影响可访问性和功能的意识、满意度和挑战。反思性专题分析用于确定我们研究的重要方面。结果:为了确保确定的主题准确地代表数据并保持其独特性,对其进行了系统的审查和改进。这一过程产生了五个主要主题:(1)医疗服务的可及性和质量;(2)健康保险的财务悖论;(3)健康保险框架中的结构和运营挑战;(4)关于健康保险的信息差距和认识;(5)关于健康保险有效性的不同经验和观点。所有与会者都同意,健康保险减少了自付医疗费用。未参保的患者将高额保费、对医疗体系的不信任以及对保险选择的了解不足作为不参保的原因。参加保险的病人对他们的保险方案表示严重不满,特别是对漫长的报销程序和不充分的医疗保险表示不满。结论:调查结果表明,喀麦隆普遍同意医疗保险的好处。为了提高参保率和满意度,需要让所有社会经济阶层的人都能负担得起保费,并考虑增加有关保险选择的信息传播和宣传。精简报销流程也至关重要。
{"title":"Exploring patient and provider perspectives on health insurance effectiveness in cameroon: a qualitative study.","authors":"Adanze Nge Cynthia, Bülent Kılıç","doi":"10.1186/s13561-025-00655-2","DOIUrl":"10.1186/s13561-025-00655-2","url":null,"abstract":"<p><strong>Background: </strong>The global push to achieve universal health coverage (UHC) by 2030 has gained widespread attention, with many countries, including low- and middle-income nations like Cameroon, striving to implement reforms. However, financial, infrastructural, and systemic barriers make achieving UHC in Cameroon challenging. In pursuit of this goal, health insurance systems, particularly private health insurance, have been increasingly promoted to reduce out-of-pocket health expenses. However, the key question remains whether patients receive value for their money. This study aimed to examine the perspectives of patients and healthcare providers on the effectiveness of health insurance in Cameroon, with a focus on awareness, satisfaction, and the challenges influencing its accessibility and functionality.</p><p><strong>Method: </strong>Following ethical approvals, this study employed a qualitative exploratory design, using key informant interviews (KII) to examine the perspectives of patients and healthcare providers on the effectiveness of health insurance in Cameroon. The study focused on awareness, satisfaction, and challenges influencing accessibility and functionality. Reflective thematic analysis was used to identify important aspects of our study.</p><p><strong>Result: </strong>To ensure that the identified themes accurately represented the data and remained distinct, they were systematically reviewed and refined. This process resulted in five main themes: (1) Accessibility and Quality of Healthcare Services, (2) The Financial Paradox of Health Insurance, (3) Structural and Operational Challenges in the Health Insurance Framework, (4) Information Gaps and Awareness about Health Insurance, and (5) Divergent Experiences and Perspectives on Health Insurance Effectiveness. All participants agreed that health insurance reduces out-of-pocket health costs. Uninsured patients cited high premiums, distrust in the healthcare system, and insufficient knowledge about insurance options as reasons for not enrolling. Insured patients expressed significant dissatisfaction with their insurance packages, particularly with lengthy reimbursement processes and inadequate medical coverage.</p><p><strong>Conclusion: </strong>The findings indicate a general agreement on the benefits of health insurance in Cameroon. To improve enrolment and satisfaction, premiums need to be made affordable across all socioeconomic levels, and consider increasing information dissemination and publicity about insurance options. Streamlining reimbursement processes is also crucial.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"59"},"PeriodicalIF":2.7,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12255117/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144620870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Economics Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1